OptimizeRx (OPRX) Research & Development (2025 - 2026)
OptimizeRx's (OPRX) quarterly Research & Development came in at $5.5 million in Q2 2026, down 5.75% year-over-year from $5.9 million in Q2 2025, and up 16.9% quarter-over-quarter from $4.7 million in Q1 2026.
Powered by 
Analysis
OptimizeRx (OPRX) Research & Development (2025 - 2026) Analysis & Trends
OptimizeRx has disclosed Research & Development across 2 years of filings, most recently posting $5.5 million for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn | 222.92 Mn |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn | 50.38 Mn |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn | 45.05 Mn |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn | 52.99 Mn |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn | 33.72 Mn |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn | 41.00 Mn |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn | 14.98 Mn |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn | 81.99 Mn |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn | 13.58 Mn |
| 10 | OptimizeRx | 148.24 Mn | 124.14 Mn | 15.69 Mn | 5.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.53 Mn |
| Mar 31, 2026 | 4.73 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 4.99 Mn |